110 related articles for article (PubMed ID: 26824991)
1. Neuronal hemoglobin in mitochondria is reduced by forming a complex with α-synuclein in aging monkey brains.
Yang W; Li X; Li X; Li X; Yu S
Oncotarget; 2016 Feb; 7(7):7441-54. PubMed ID: 26824991
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.
Vasquez V; Mitra J; Hegde PM; Pandey A; Sengupta S; Mitra S; Rao KS; Hegde ML
J Alzheimers Dis; 2017; 60(s1):S133-S150. PubMed ID: 28731447
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeted Oligomeric α-Synuclein Induces TOM40 Degradation and Mitochondrial Dysfunction in Parkinson's Disease and Parkinsonism-Dementia of Guam.
Hegde M; Vasquez V; Kodavati M; Mitra J; Vendula I; Hamilton D; Garruto R; Rao KS
Res Sq; 2024 Feb; ():. PubMed ID: 38464024
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial transfer of α-synuclein mediates carbon disulfide-induced mitochondrial dysfunction and neurotoxicity.
Liu Z; Shan S; Kang K; Wang S; Yong H; Sun Y; Bai Y; Song F
Ecotoxicol Environ Saf; 2024 Jun; 281():116613. PubMed ID: 38908057
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.
Daniele S; Pietrobono D; Fusi J; Lo Gerfo A; Cerri E; Chico L; Iofrida C; Petrozzi L; Baldacci F; Giacomelli C; Galetta F; Siciliano G; Bonuccelli U; Trincavelli ML; Franzoni F; Martini C
Front Aging Neurosci; 2018; 10():17. PubMed ID: 29441013
[TBL] [Abstract][Full Text] [Related]
6. Defining a role for hemoglobin in Parkinson's disease.
Freed J; Chakrabarti L
NPJ Parkinsons Dis; 2016; 2():16021. PubMed ID: 28725702
[TBL] [Abstract][Full Text] [Related]
7. Engineered antibody therapies coming of age for aging brains.
Messer A
Mol Ther; 2014 Oct; 22(10):1725-7. PubMed ID: 25269943
[No Abstract] [Full Text] [Related]
8. GABA transmission via ATP-dependent K+ channels regulates α-synuclein secretion in mouse striatum.
Emmanouilidou E; Minakaki G; Keramioti MV; Xylaki M; Balafas E; Chrysanthou-Piterou M; Kloukina I; Vekrellis K
Brain; 2016 Mar; 139(Pt 3):871-90. PubMed ID: 26912647
[TBL] [Abstract][Full Text] [Related]
9. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
[TBL] [Abstract][Full Text] [Related]
10. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade.
Matsuda N
J Biochem; 2016 Apr; 159(4):379-85. PubMed ID: 26839319
[TBL] [Abstract][Full Text] [Related]
11. Clueless is a conserved ribonucleoprotein that binds the ribosome at the mitochondrial outer membrane.
Sen A; Cox RT
Biol Open; 2016 Feb; 5(2):195-203. PubMed ID: 26834020
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.
Rasheed MZ; Tabassum H; Parvez S
Protoplasma; 2017 Jan; 254(1):33-42. PubMed ID: 26825389
[TBL] [Abstract][Full Text] [Related]
13. Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.
Iljina M; Garcia GA; Horrocks MH; Tosatto L; Choi ML; Ganzinger KA; Abramov AY; Gandhi S; Wood NW; Cremades N; Dobson CM; Knowles TP; Klenerman D
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1206-15. PubMed ID: 26884195
[TBL] [Abstract][Full Text] [Related]
14. The relationship between glucocerebrosidase mutations and Parkinson disease.
Migdalska-Richards A; Schapira AH
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
[TBL] [Abstract][Full Text] [Related]
15. New and emerging medical therapies in Parkinson's disease.
Lotia M; Jankovic J
Expert Opin Pharmacother; 2016; 17(7):895-909. PubMed ID: 26830844
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Anti-α-Synuclein Immunotherapy.
Lee JS; Lee SJ
J Mov Disord; 2016 Jan; 9(1):14-9. PubMed ID: 26828212
[TBL] [Abstract][Full Text] [Related]
17. Increasing tetrahydrobiopterin in cardiomyocytes adversely affects cardiac redox state and mitochondrial function independently of changes in NO production.
Sethumadhavan S; Whitsett J; Bennett B; Ionova IA; Pieper GM; Vasquez-Vivar J
Free Radic Biol Med; 2016 Apr; 93():1-11. PubMed ID: 26826575
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity.
Bollimpelli VS; Kumar P; Kumari S; Kondapi AK
Neurochem Int; 2016 May; 95():37-45. PubMed ID: 26826319
[TBL] [Abstract][Full Text] [Related]
19. Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.
Chen M; Yang W; Li X; Li X; Wang P; Yue F; Yang H; Chan P; Yu S
Oncotarget; 2016 Feb; 7(8):8466-80. PubMed ID: 27032368
[TBL] [Abstract][Full Text] [Related]
20. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.
Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H
Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
